Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burger

Showing results (921-930 of 1,155) with videos related to

Pageof 116
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 2021
Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control studyE L K Voogt, D P Schaap, K van den Berg, et al.
BJS Open|May 13, 2022
MRI tumour regression grade in locally recurrent rectal cancerEva L K Voogt, Stefi Nordkamp, Desley M G I van Zoggel, et al.
BMJ Open|December 30, 2023
Optimisation of Organ Preservation treatment strategies in patients with rectal cancer with a good clinical response after neoadjuvant (chemo)radiotherapy: Additional contact X-ray brachytherapy versus eXtending the observation period and local excision (OPAXX) - protocol for two multicentre, parallel, single-arm, phase II studiesBarbara M Geubels, Baukelien van Triest, Femke P Peters, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 10, 2019
Association between vertebral bone mineral density, myocardial perfusion, and long-term cardiovascular outcomes: A sex-specific analysisMichael Fiechter, Susan Bengs, Andrea Roggo, et al.
Oncoimmunology|April 11, 2018
Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapySimon Schliffke, Mariela Sivina, Ekaterina Kim, et al.
Molecular Imaging and Biology|June 5, 2025
Long-term Local Control Following CEA-targeted Fluorescence-guided Surgery in Patients With Locally Advanced and Recurrent Rectal CancerMats I Warmerdam, Davy M J Creemers, Miranda Kusters, et al.
Blood|July 10, 2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapyFarhad Ravandi, Jeffrey L Jorgensen, Deborah A Thomas, et al.
Blood|February 21, 2015
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinibJohn C Byrd, Richard R Furman, Steven E Coutre, et al.
Cancers|February 11, 2023
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal MetastasesVincent C J van de Vlasakker, Teun B M van den Heuvel, Anouk Rijken, et al.
Journal of Geriatric Oncology|May 3, 2026
A multidisciplinary care pathway for colorectal carcinoma: Impact on treatment decisionsJ Lagarde, E Banken, I E G van Hellemond, et al.
Pageof 116

Showing results (921-930 of 1,155) with videos related to

Sort By:
Pageof 116
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 2021
Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control studyE L K Voogt, D P Schaap, K van den Berg, et al.
BJS Open|May 13, 2022
MRI tumour regression grade in locally recurrent rectal cancerEva L K Voogt, Stefi Nordkamp, Desley M G I van Zoggel, et al.
BMJ Open|December 30, 2023
Optimisation of Organ Preservation treatment strategies in patients with rectal cancer with a good clinical response after neoadjuvant (chemo)radiotherapy: Additional contact X-ray brachytherapy versus eXtending the observation period and local excision (OPAXX) - protocol for two multicentre, parallel, single-arm, phase II studiesBarbara M Geubels, Baukelien van Triest, Femke P Peters, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 10, 2019
Association between vertebral bone mineral density, myocardial perfusion, and long-term cardiovascular outcomes: A sex-specific analysisMichael Fiechter, Susan Bengs, Andrea Roggo, et al.
Oncoimmunology|April 11, 2018
Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapySimon Schliffke, Mariela Sivina, Ekaterina Kim, et al.
Molecular Imaging and Biology|June 5, 2025
Long-term Local Control Following CEA-targeted Fluorescence-guided Surgery in Patients With Locally Advanced and Recurrent Rectal CancerMats I Warmerdam, Davy M J Creemers, Miranda Kusters, et al.
Blood|July 10, 2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapyFarhad Ravandi, Jeffrey L Jorgensen, Deborah A Thomas, et al.
Blood|February 21, 2015
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinibJohn C Byrd, Richard R Furman, Steven E Coutre, et al.
Cancers|February 11, 2023
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal MetastasesVincent C J van de Vlasakker, Teun B M van den Heuvel, Anouk Rijken, et al.
Journal of Geriatric Oncology|May 3, 2026
A multidisciplinary care pathway for colorectal carcinoma: Impact on treatment decisionsJ Lagarde, E Banken, I E G van Hellemond, et al.
Pageof 116